AstraZeneca to discover drugs with U.K. cancer groups

AstraZeneca pledged about $6.3 million for a drug-development deal with Cancer Research Technology and the Institute of Cancer Research in the U.K. The three-year joint venture will focus on molecular chaperones, which were found to support the survival of cancer cells.

View Full Article in:

Telegraph (London) (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX